Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 646–660 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4105 SERPINC1 Gene Antithrombin III Deficiency Genetic Test This genetic test evaluates the SERPINC1 gene for mutations causing hereditary antithrombin III deficiency.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SERPINC1 gene sequence", "Single nucleotide variants", "Small indels", "Copy number variations (CNV)"] Parameters [] Preparation ["Genetic counseling session is mandatory prior to sample collection.", "No specific fasting or medication adjustments are required for the blood draw."] Indications ["Personal or family history of venous thromboembolism (VTE)", "Unexplained recurrent miscarriage", "Pre-surgical risk assessment for thrombophilia", "Evaluation of suspected hereditary antithrombin deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 90368-6 ICD-10: D68.51 Clinical summary This genetic test evaluates the SERPINC1 gene for mutations causing hereditary antithrombin III deficiency.
TEST-4924 SETD5 Gene Genetic Test for Autosomal Dominant Intellectual Disability Type 23 (MRD23) This test detects pathogenic variants in the SETD5 gene associated with autosomal dominant intellectual disability type 23 (MRD23).	Whole Blood (3 mL)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SETD5 gene"] Parameters [] Preparation ["Genetic counseling is mandatory before testing.", "Informed consent must be obtained.", "Minors require parental or guardian consent."] Indications ["Suspected autosomal dominant intellectual disability type 23 (MRD23)", "Family history of intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: F79, Z14.8, Z13.79 Clinical summary This test detects pathogenic variants in the SETD5 gene associated with autosomal dominant intellectual disability type 23 (MRD23).
TEST-5864 SFTPB Gene Surfactant Metabolism Dysfunction Type 1 Genetic Test This test evaluates the SFTPB gene for pathogenic variants associated with surfactant metabolism dysfunction type 1.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SFTPB gene", "Surfactant metabolism dysfunction type 1"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory.", "A detailed family pedigree is required."] Indications ["Infants with unexplained respiratory distress", "Family history of the disease", "Carrier screening in at-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 93239-9 ICD-10: P27.0 Clinical summary This test evaluates the SFTPB gene for pathogenic variants associated with surfactant metabolism dysfunction type 1.
TEST-4726 SGCA Gene Limb‑Girdle Muscular Dystrophy Type 2D Genetic Test This genetic test identifies pathogenic variants in the SGCA gene associated with Limb-Girdle Muscular Dystrophy Type 2D (LGMD2D).	Peripheral Whole Blood (EDTA)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SGCA gene", "SNVs, indels, and copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Suspected diagnosis of Limb-Girdle Muscular Dystrophy Type 2D", "Family history of LGMD2D", "Carrier screening in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 95983-4 ICD-10: G71.0, Z14.8, Z13.79 Clinical summary This genetic test identifies pathogenic variants in the SGCA gene associated with Limb-Girdle Muscular Dystrophy Type 2D (LGMD2D).
TEST-5873 SI Gene Sucrase-Isomaltase Deficiency Genetic Test This test evaluates the SI gene for pathogenic variants associated with congenital sucrase-isomaltase deficiency (CSID).	Peripheral Whole Blood or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SI gene", "Genetic mutations affecting sucrase-isomaltase enzyme production"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected congenital sucrase-isomaltase deficiency (CSID)", "Chronic diarrhoea unresponsive to standard treatment", "Family history of CSID"] Measurement technique Confirm with laboratory Codes LOINC: 81319-8 ICD-10: E74.31 Clinical summary This test evaluates the SI gene for pathogenic variants associated with congenital sucrase-isomaltase deficiency (CSID).
TEST-3800 SIGMAR1 Gene ALS Type 16 Genetic Test This test identifies pathogenic variants within the SIGMAR1 gene associated with Amyotrophic Lateral Sclerosis Type 16 (ALS16).	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SIGMAR1 gene", "Presence of mutations linked to ALS16"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of ALS type 16", "Family history of ALS16", "Genetic risk assessment for ALS16"] Measurement technique Confirm with laboratory Codes LOINC: 94436-0 ICD-10: G12.21 Clinical summary This test identifies pathogenic variants within the SIGMAR1 gene associated with Amyotrophic Lateral Sclerosis Type 16 (ALS16).
TEST-3922 SLC12A1 Gene (Bartter Syndrome Type 1) Next-Generation Sequencing (NGS) Genetic Test This test evaluates the SLC12A1 gene for pathogenic variants associated with Bartter syndrome type 1.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC12A1 gene", "Copy number alterations in the SLC12A1 gene"] Parameters [] Preparation ["No fasting required", "Genetic counselling session mandatory prior to collection"] Indications ["Suspected Bartter syndrome type 1", "Family history of Bartter syndrome type 1", "Recurrent unexplained hypokalemia", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21634-2 ICD-10: E26.81 Clinical summary This test evaluates the SLC12A1 gene for pathogenic variants associated with Bartter syndrome type 1.
TEST-3933 SLC12A2 Gene Next-Generation Sequencing (Genetic Test for Bartter Syndrome This test analyzes the entire SLC12A2 gene to detect pathogenic variants associated with Bartter syndrome type 1.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC12A2 gene", "Na-K-2Cl cotransporter (NKCC1) function"] Parameters [] Preparation ["Complete a formal genetic counselling session", "Provide a detailed three-generation family pedigree", "Maintain normal hydration", "No fasting required"] Indications ["Suspected Bartter syndrome type 1 based on clinical presentation", "Family history of Bartter syndrome", "Carrier screening for family members", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94220-2 ICD-10: E26.81 Clinical summary This test analyzes the entire SLC12A2 gene to detect pathogenic variants associated with Bartter syndrome type 1.
TEST-3878 SLC12A7 Gene Bartter Syndrome Genetic Test This test evaluates the SLC12A7 gene for pathogenic variants associated with Bartter syndrome.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in SLC12A7 gene", "Copy Number Variants (CNVs) in SLC12A7 gene"] Parameters [] Preparation ["Do not discontinue prescribed medications without consulting your physician"] Indications ["Clinical diagnosis of Bartter syndrome", "Carrier screening", "Family risk stratification"] Measurement technique Confirm with laboratory Codes LOINC: 21674-2 ICD-10: E26.81, R79.8 Clinical summary This test evaluates the SLC12A7 gene for pathogenic variants associated with Bartter syndrome.
TEST-6355 SLC16A1 Gene Erythrocyte Lactate Transporter Defect Genetic Test This genetic test identifies pathogenic variants in the SLC16A1 gene, which encodes the erythrocyte lactate transporter MCT1.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC16A1 gene sequence", "Pathogenic variants in SLC16A1"] Parameters [] Preparation ["Do not discontinue prescribed medication without physician instruction", "Inform phlebotomist if on anticoagulant therapy"] Indications ["Unexplained exercise intolerance", "Hyperlactatemia", "Suspected metabolic disorder related to lactate transport"] Measurement technique Confirm with laboratory Codes LOINC: 92834-7 ICD-10: E74.81 Clinical summary This genetic test identifies pathogenic variants in the SLC16A1 gene, which encodes the erythrocyte lactate transporter MCT1.
TEST-6233 SLC16A1 Gene Hyperinsulinemic Hypoglycemia Type 7 Genetic Test This test identifies genetic mutations in the SLC16A1 gene associated with congenital hyperinsulinemic hypoglycemia type 7.	Whole blood (EDTA) or dried blood spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC16A1 gene", "Mutation types (missense, nonsense, frameshift, splice-site)"] Parameters [] Preparation ["Inform phlebotomist of all current medications", "No specific fasting required for blood draw"] Indications ["Suspected congenital hyperinsulinemic hypoglycemia type 7", "Familial history of hyperinsulinemic hypoglycemia", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82619-4 ICD-10: E16.1 Clinical summary This test identifies genetic mutations in the SLC16A1 gene associated with congenital hyperinsulinemic hypoglycemia type 7.
TEST-5952 SLC16A1 Gene Monocarboxylate Transporter 1 Deficiency Genetic Test This genetic test identifies pathogenic variants in the SLC16A1 gene associated with Monocarboxylate Transporter 1 deficiency.	Whole Blood (EDTA), Extracted DNA, or FTA Card	21 – 28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC16A1 gene", "SNVs", "Indels", "CNVs"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected Monocarboxylate Transporter 1 deficiency", "Family history of the disorder", "Unexplained exercise-induced metabolic crises"] Measurement technique Confirm with laboratory Codes LOINC: 31209-3 ICD-10: E71.32 Clinical summary This genetic test identifies pathogenic variants in the SLC16A1 gene associated with Monocarboxylate Transporter 1 deficiency.
TEST-5544 SLC16A2 Gene Pelizaeus‑Merzbacher Disease & Allan‑Herndon‑Dudley Syndrome Genetic Test This genetic test evaluates the SLC16A2 (MCT8) gene for pathogenic variants associated with Pelizaeus‑Merzbacher disease and Allan‑Herndon‑Dudley syndrome.	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC16A2 gene", "Full coding regions and splice sites"] Parameters [] Preparation ["No fasting required", "No medication adjustment required unless instructed by physician"] Indications ["Suspected Pelizaeus‑Merzbacher disease", "Suspected Allan‑Herndon‑Dudley syndrome", "Family history of SLC16A2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82992-1 ICD-10: E71.1, E75.23 Clinical summary This genetic test evaluates the SLC16A2 (MCT8) gene for pathogenic variants associated with Pelizaeus‑Merzbacher disease and Allan‑Herndon‑Dudley syndrome.
TEST-4378 SLC19A3 Gene Encephalopathy Thiamine-Responsive Genetic Test This test identifies pathogenic variants in the SLC19A3 gene associated with thiamine-transporter-2 deficiency.	Whole Blood or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC19A3 gene"] Parameters [] Preparation [] Indications ["Suspected thiamine-transporter-2 deficiency", "Unexplained encephalopathy", "Family history of related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 77074-2 ICD-10: E53.8 Clinical summary This test identifies pathogenic variants in the SLC19A3 gene associated with thiamine-transporter-2 deficiency.
TEST-4390 SLC1A3 Gene Episodic Ataxia Type 6 Genetic Test This test evaluates the SLC1A3 gene for mutations associated with Episodic Ataxia Type 6.	Whole Blood, Extracted DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC1A3 gene coding region", "Copy Number Variations (CNV) in SLC1A3"] Parameters [] Preparation ["Genetic counselling session required", "Clinical history must be provided"] Indications ["Confirmation of clinical diagnosis of Episodic Ataxia Type 6", "Genetic risk assessment for family members"] Measurement technique Confirm with laboratory Codes LOINC: 94075-0 ICD-10: G11.8 Clinical summary This test evaluates the SLC1A3 gene for mutations associated with Episodic Ataxia Type 6.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.